INCY vs GILD: Which Stock is Better?
Side-by-side comparison of Incyte Corp and Gilead Sciences Inc in 2026
INCY
Incyte Corp
$101.27
GILD
Gilead Sciences Inc
$148.95
Key Metrics Comparison
| Metric | INCY | GILD | Winner |
|---|---|---|---|
| Market Cap | $20.15B | $184.91B | GILD |
| P/E Ratio | 15.80 | 21.97 | INCY |
| EPS (TTM) | $6.41 | $6.78 | GILD |
| Revenue Growth | 0.3% | 0.0% | INCY |
| Gross Margin | 52.9% | 78.8% | GILD |
Analyze INCY
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INCY or GILD a better investment?
Comparing INCY and GILD: Incyte Corp has a market cap of $20.15B while Gilead Sciences Inc has $184.91B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INCY and GILD?
INCY (Incyte Corp) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INCY or GILD?
Based on P/E ratios, INCY trades at a lower multiple (15.8x vs 22.0x).
Which is growing faster: INCY or GILD?
INCY has higher revenue growth at 0.3% vs 0.0% for GILD.
Which company is more profitable: INCY or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 52.9% for INCY.
Which is the larger company: INCY or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $184.91B compared to $20.15B for INCY.
Should I buy INCY or GILD in 2026?
Both INCY and GILD have investment merit. INCY trades at $101.27 while GILD trades at $148.95. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INCY and GILD stock?
Key differences: Market Cap ($20.15B vs $184.91B), P/E Ratio (15.8x vs 22.0x), Revenue Growth (0.3% vs 0.0%), Gross Margin (52.9% vs 78.8%).